relative to increasing transparency in the 340B Drug Pricing Program.
Refer to Interim Study, MA, VV; 03/05/2026; SJ 5
Email me when SB 477 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 477. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would make nonprofit hospitals and their contracted pharmacies submit annual, item‑by‑item reports on 340B drug use, costs, reimbursements and charity care. It also mandates claim‑level identifiers, a public de‑identified dashboard, and patient‑facing notices, aiming to prevent duplicate discounts and improve public insight into the program.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 477
3 free questions a day, no accountHistory
- Refer to Interim Study, MA, VV; 03/05/2026; SJ 5
- Special Order to the Next Session, Without Objection, MA; 02/19/2026; SJ 4
- SB 477 was Removed from the Consent Calendar; 02/19/2026; SJ 4
- Committee Report: Referred to Interim Study, 03/05/2026, Vote 5-0; SC 8
- Committee Report: Referred to Interim Study, 02/19/2026; Vote 5-0; CC; SC 6
- Hearing: 01/21/2026, Room 100, SH, 01:30 pm; SC 2
- Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1
Sponsors
- Tim McGough (R) · sponsor
- Bill M. Gannon
- Brian D Cole
- Daniel E. Innis
- Howard Pearl
- Julie Miles
- Katelyn T Kuttab
- Keith Michael Ammon
- Regina Birdsell
- Wayne D. MacDonald
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 477 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 477 freeOr ask your AI assistant about SB 477 directly:
Add to Claude, ChatGPT or Cursor